MARRONE BIO INNOVATIONS INC. Proceeds from Warrant Exercises
MARRONE BIO INNOVATIONS INC. reported Proceeds from Warrant Exercises of $9.72 million for the 12-month period ending 2021-12-31, per its 10-K/A filed 2022-05-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromWarrantExercises · last filed 2022-05-13
- MARRONE BIO INNOVATIONS INC. proceeds from warrant exercises for the quarter ending 2021-12-31 was $3.54M, a 69.15% decline year-over-year.
- MARRONE BIO INNOVATIONS INC. proceeds from warrant exercises for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- MARRONE BIO INNOVATIONS INC. proceeds from warrant exercises for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- MARRONE BIO INNOVATIONS INC. proceeds from warrant exercises for the quarter ending 2021-03-31 was $6.17M, a 2.92% increase year-over-year.
- MARRONE BIO INNOVATIONS INC. proceeds from warrant exercises for fiscal 2021 was $9.72M, a 55.96% decline from fiscal 2020.
- MARRONE BIO INNOVATIONS INC. proceeds from warrant exercises for fiscal 2020 was $22.07M, a 37.95% increase from fiscal 2019.
- MARRONE BIO INNOVATIONS INC. proceeds from warrant exercises for fiscal 2019 was $16.00M, a 16226.53% increase from fiscal 2018.
- MARRONE BIO INNOVATIONS INC. proceeds from warrant exercises for fiscal 2018 was $98.00K.
| Period end | Proceeds from Warrant Exercises 3 month | Proceeds from Warrant Exercises 6 month | Proceeds from Warrant Exercises 9 month | Proceeds from Warrant Exercises 12 month |
|---|---|---|---|---|
| 2021-12-31 | $3.54M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-05-09 | $3.54M derived: sum of 2 quarters · filed 2022-05-09 | $3.54M derived: sum of 3 quarters · filed 2022-05-09 | $9.72M 10-K/A · filed 2022-05-09 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $6.17M 10-Q · filed 2021-11-10 | $17.67M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $6.17M 10-Q · filed 2021-08-16 | $17.67M derived: sum of 3 quarters · filed 2022-05-13 | $19.70M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-03-31 | $6.17M 10-Q · filed 2022-05-13 | $17.67M derived: sum of 2 quarters · filed 2022-05-13 | $19.70M derived: sum of 3 quarters · filed 2022-05-13 | $22.25M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $11.49M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-05-09 | $13.53M derived: sum of 2 quarters · filed 2022-05-09 | $16.07M derived: sum of 3 quarters · filed 2022-05-09 | $22.07M 10-K/A · filed 2022-05-09 |
| 2020-09-30 | $2.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $4.58M derived: sum of 2 quarters · filed 2021-11-10 | $10.58M 10-Q · filed 2021-11-10 | $16.58M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $2.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $8.54M 10-Q · filed 2021-08-16 | $14.54M derived: sum of 3 quarters · filed 2021-08-16 | |
| 2020-03-31 | $6.00M 10-Q · filed 2021-05-13 | $12.00M derived: sum of 2 quarters · filed 2021-05-13 | ||
| 2019-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $16.00M 10-K · filed 2021-03-23 | ||
| 2019-09-30 | $10.00M 10-Q · filed 2020-11-09 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $98.00K 10-K · filed 2020-03-16 | ||
| 2018-09-30 | $98.00K 10-Q · filed 2019-11-19 |